Ligandal Competitors and Similar CompaniesClear all

Ligandal's competitors and similar companies include Sinon Therapeutics, Nanomi, JINIS Biopharmaceuticals and Privo Technologies.
Ligandal
Ligandal
Ligandal is a company creating tailored gene therapies using non-viral, cell-specifically-targeted nanotechnology.
Sinon Therapeutics
Sinon Therapeutics
Sinon Therapeutics is a company specializing in neurological diseases.
Nanomi
Nanomi
Nanomi is a company that specializes in the field of microspheres and nanoparticles.
JINIS Biopharmaceuticals
JINIS Biopharmaceuticals
JINIS Biopharmaceuticals (주)지니스) is a company that provides custom development and production of nanoparticles for biomedical research and the development of nanomedicines.
Privo Technologies
Privo Technologies
Privo Technologies is a biotechnology company that develops therapeutics to eliminate cancers and prevent recurrence.
Founding Date
Founding Date
2013
Founding Date
N/A
Founding Date
2004
Founding Date
2000
Founding Date
2016
Type
Type
Private
Type
Private
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
San Francisco, US HQ
Locations
Durham, US HQ
Locations
Oldenzaal, NL HQ
Locations
HQ
Locations
Peabody, US HQ
Employees
Employees
12
Employees
3
Employees
502% decrease
Employees
20
Employees
147% decrease
For sources of this data, please see the company profile

View Company Profiles

Sinon Therapeutics
HQ
Durham, US
Employees
3

Sinon Therapeutics is a company specializing in neurological diseases.

View company
Nanomi
HQ
Oldenzaal, NL

Nanomi is a company that specializes in the field of microspheres and nanoparticles.

View company
JINIS Biopharmaceuticals
HQ
Employees
20

JINIS Biopharmaceuticals (주)지니스) is a company that provides custom development and production of nanoparticles for biomedical research and the development of nanomedicines.

View company
Privo Technologies
HQ
Peabody, US
Employees
14↓ 7% decrease

Privo Technologies is a biotechnology company that develops therapeutics to eliminate cancers and prevent recurrence.

View company